...
首页> 外文期刊>Journal of investigative medicine >Changes in calcium channel proteins according to magnesium sulfate administration in placentas from pregnancies with pre-eclampsia or fetal growth restriction
【24h】

Changes in calcium channel proteins according to magnesium sulfate administration in placentas from pregnancies with pre-eclampsia or fetal growth restriction

机译:根据胎盘脂肪酸镁给药的钙通道蛋白的变化来自预妊娠妊娠期或胎儿生长限制的妊娠

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We aimed to evaluate the changes in plasma membrane Ca2+-ATPase (PMCA) and sarcoendoplasmic reticulum CA(2+)-ATPase (SERCA-2) according to the antepartal magnesium sulfate (MgSO4) administration in the placentas from pregnancies with pre-eclampsia (PE) or fetal growth restriction (FGR). Pregnant women were classified as follows: (group 1) pregnancies without PE or FGR (n=16), (group 2) pregnancies with PE or FGR but without MgSO4 administration (n=14), and (group 3) pregnancies with PE or FGR and with MgSO4 administration (n=28). We observed the localization of PMCA and SERCA-2 in placentas and compared its expression among 3 groups. And we observed its expression in BeWo cells following treatment with MgSO4 and CoCl 2. PMCA staining was more observed in the basal membrane, whereas SERCA-2 staining was observed predominantly under the microvillous membrane. SERCA-2 expression was significantly increased in group 3 compared with that in group 1. Considering the gestational age at delivery, PMCA expression was increased in group 2 and group 3 compared with that in group 1 after 36 weeks of gestation. SERCA-2 was increased in group 3, but not in group 2 compared with that in group 1 after 36 weeks of gestation. In BeWo cells, MgSO4 treatment increased PMCA and SERCA-2 expression. PMCA expression was influenced by gestational age at delivery, and SERCA-2 expression was increased in the presence of PE and antepartal MgSO4 administration. This indicates that antepartal MgSO4 administration has a greater influence on SERCA-2 than PMCA.
机译:我们的旨在根据胎儿妊娠期妊娠期妊娠( PE)或胎儿生长限制(FGR)。孕妇被归类如下:(第1组)没有PE或FGR(n = 16),(第2组)具有PE或FGR的妊娠,但没有MgSO4给药(n = 14),和(第3组)与PE或PE妊娠FGR和用MgSO4给药(n = 28)。我们观察了PMCA和Serca-2在胎盘中的定位,并将其表达与3组相比。并且我们在用MgSO4和COCL 2处理后观察到Bewo细胞中的表达。在基础膜中更长观察到PMCA染色,而主要在微毛膜下观察到Serca-2染色。与第1组相比,Serca-2表达明显增加。考虑到递送时的孕龄,第2组和第3组在第2组中增加了PMCA表达,与第1组在妊娠36周后。第3组中塞卡-2增加,但在第2组中,与妊娠36周后第1组相比。在Bewo细胞中,MgSO4处理增加了PMCA和Serca-2表达。 PMCA表达受到胎儿在递送时的影响,并且在体育和育术MgSO 4给药的存在下增加了Serca-2表达。这表明南甲醛MgSO4给药对Serca-2的影响比PMCA更大。

著录项

  • 来源
    《Journal of investigative medicine》 |2019年第2期|共8页
  • 作者单位

    Kyungpook Natl Univ Sch Med Kyungpook Natl Univ Hosp Dept Obstet &

    Gynecol Daegu South Korea;

    Sungkynkwan Univ Sch Med Samsung Biomed Res Inst Samsung Med Ctr Seoul South Korea;

    Sungkyunkwan Univ Sch Med Kangbuk Samsung Hosp Dept Obstet &

    Gynecol Seoul South Korea;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Obstet &

    Gynecol Seoul 135710 South Korea;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Obstet &

    Gynecol Seoul 135710 South Korea;

    Sungkyunkwan Univ Sch Med Samsung Med Ctr Dept Obstet &

    Gynecol Seoul 135710 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 诊断学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号